Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) (346551)

    From US Department of Health & Human Services: National Institutes of Health (NIH)

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

    Type of Support

    Overview

    The funding opportunity aims to support translational and clinical research focused on advancing precision medicine for pregnant and lactating persons, as well as children. The grants are intended to fund projects that develop novel tools, models, and technologies with the potential for direct clinical or health impacts. Specifically, the grant supports efforts to enhance understanding of drug actions, including pediatric ontogeny and physiological changes during pregnancy and lactation, and to discover or improve therapeutics for safer and more effective medication use in these populations. The overarching goal is to enhance the safety and effectiveness of precision therapeutics for pregnant and lactating individuals, fetuses, neonates, and children, including those with disabilities.

    Eligibility

    Organization's Location
    cillum ad
    Program Location
    ullamco
    Organization Type

    Submission

    Schedule
    Step 1: commodo do commodo
    Step 2: tempor veniam (mollit cupidatat)
    2 of 2 free pages viewed this month
    Sign up to view this and 12k+ more grant opportunities
    or
    Already have an account?Log in